These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
405 related articles for article (PubMed ID: 30880491)
1. Combined using of paclitaxel and salinomycin active targeting nanostructured lipid carriers against non-small cell lung cancer and cancer stem cells. Zhou J; Sun M; Jin S; Fan L; Zhu W; Sui X; Cao L; Yang C; Han C Drug Deliv; 2019 Dec; 26(1):281-289. PubMed ID: 30880491 [TBL] [Abstract][Full Text] [Related]
2. Polyarginine and PEG-AEYLR comodified nanostructured lipid carrier: 10mol% uncleavable PEG-AEYLR showed no shielding effect to polyarginine in vitro while maintaining good tumor targeting in vivo. Sun M; Zhu Z; Wang H; Jin S; Yang X; Han C; Pan W Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):284-292. PubMed ID: 28355889 [TBL] [Abstract][Full Text] [Related]
3. Lung cancer combination therapy: co-delivery of paclitaxel and doxorubicin by nanostructured lipid carriers for synergistic effect. Wang Y; Zhang H; Hao J; Li B; Li M; Xiuwen W Drug Deliv; 2016 May; 23(4):1398-403. PubMed ID: 26079530 [TBL] [Abstract][Full Text] [Related]
4. Targeted lung cancer therapy: preparation and optimization of transferrin-decorated nanostructured lipid carriers as novel nanomedicine for co-delivery of anticancer drugs and DNA. Shao Z; Shao J; Tan B; Guan S; Liu Z; Zhao Z; He F; Zhao J Int J Nanomedicine; 2015; 10():1223-33. PubMed ID: 25709444 [TBL] [Abstract][Full Text] [Related]
5. Redox sensitive PEG controlled octaarginine and targeting peptide co-modified nanostructured lipid carriers for enhanced tumour penetrating and targeting in vitro and in vivo. Wang H; Sun M; Li D; Yang X; Han C; Pan W Artif Cells Nanomed Biotechnol; 2018 Mar; 46(2):313-322. PubMed ID: 28362124 [TBL] [Abstract][Full Text] [Related]
6. The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles. Zhang Y; Zhang H; Wang X; Wang J; Zhang X; Zhang Q Biomaterials; 2012 Jan; 33(2):679-91. PubMed ID: 22019123 [TBL] [Abstract][Full Text] [Related]
7. Lipoprotein-Inspired Nanocarrier Composed of Folic Acid-Modified Protein and Lipids: Preparation and Evaluation of Tumor-Targeting Effect. Han M; Ji X; Li J; Ge Z; Luo B; Zhou K; Wang Q; Sun X; Zhang W; Li J Int J Nanomedicine; 2020; 15():3433-3445. PubMed ID: 32523342 [TBL] [Abstract][Full Text] [Related]
8. Which one performs better for targeted lung cancer combination therapy: pre- or post-bombesin-decorated nanostructured lipid carriers? Du J; Li L Drug Deliv; 2016 Jun; 23(5):1799-809. PubMed ID: 26455787 [TBL] [Abstract][Full Text] [Related]
9. Targeted Delivery of Combination Therapeutics Using Monoclonal Antibody 2C5-Modified Immunoliposomes for Cancer Therapy. Narayanaswamy R; Torchilin VP Pharm Res; 2021 Mar; 38(3):429-450. PubMed ID: 33655395 [TBL] [Abstract][Full Text] [Related]
10. Nanostructured lipid carriers as novel drug delivery system for lung cancer gene therapy. Han Y; Li Y; Zhang P; Sun J; Li X; Sun X; Kong F Pharm Dev Technol; 2016; 21(3):277-81. PubMed ID: 25560648 [TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-coated nanostructured lipid carriers for targeting paclitaxel to cancer. Yang XY; Li YX; Li M; Zhang L; Feng LX; Zhang N Cancer Lett; 2013 Jul; 334(2):338-45. PubMed ID: 22776563 [TBL] [Abstract][Full Text] [Related]
12. Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells. Zeng YB; Yu ZC; He YN; Zhang T; Du LB; Dong YM; Chen HW; Zhang YY; Wang WQ Acta Pharmacol Sin; 2018 Feb; 39(2):261-274. PubMed ID: 29388568 [TBL] [Abstract][Full Text] [Related]
13. Small peptide-modified nanostructured lipid carriers distribution and targeting to EGFR-overexpressing tumor in vivo. Han C; Li Y; Sun M; Liu C; Ma X; Yang X; Yuan Y; Pan W Artif Cells Nanomed Biotechnol; 2014 Jun; 42(3):161-6. PubMed ID: 23731383 [TBL] [Abstract][Full Text] [Related]
14. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells. Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270 [TBL] [Abstract][Full Text] [Related]
15. Self-targeted salinomycin-loaded DSPE-PEG-methotrexate nanomicelles for targeting both head and neck squamous cell carcinoma cancer cells and cancer stem cells. Zhu M; Chen S; Hua L; Zhang C; Chen M; Chen D; Dong Y; Zhang Y; Li M; Song X; Chen H; Zheng H Nanomedicine (Lond); 2017 Feb; 12(4):295-315. PubMed ID: 28093940 [TBL] [Abstract][Full Text] [Related]
16. Dimeric c(RGD) peptide conjugated nanostructured lipid carriers for efficient delivery of Gambogic acid to breast cancer. Kebebe D; Wu Y; Zhang B; Yang J; Liu Y; Li X; Ma Z; Lu P; Liu Z; Li J Int J Nanomedicine; 2019; 14():6179-6195. PubMed ID: 31447559 [No Abstract] [Full Text] [Related]
17. Preparation and characterization of photo-responsive cell-penetrating peptide-mediated nanostructured lipid carrier. Yang Y; Yang Y; Xie X; Cai X; Mei X J Drug Target; 2014 Dec; 22(10):891-900. PubMed ID: 25045925 [TBL] [Abstract][Full Text] [Related]
18. Near-infrared mediated quantum dots and paclitaxel co-loaded nanostructured lipid carriers for cancer theragnostic. Olerile LD; Liu Y; Zhang B; Wang T; Mu S; Zhang J; Selotlegeng L; Zhang N Colloids Surf B Biointerfaces; 2017 Feb; 150():121-130. PubMed ID: 27907859 [TBL] [Abstract][Full Text] [Related]
19. CD44 targeted chemotherapy for co-eradication of breast cancer stem cells and cancer cells using polymeric nanoparticles of salinomycin and paclitaxel. Muntimadugu E; Kumar R; Saladi S; Rafeeqi TA; Khan W Colloids Surf B Biointerfaces; 2016 Jul; 143():532-546. PubMed ID: 27045981 [TBL] [Abstract][Full Text] [Related]
20. Tumor-targeted polymeric nanostructured lipid carriers with precise ratiometric control over dual-drug loading for combination therapy in non-small-cell lung cancer. Liang Y; Tian B; Zhang J; Li K; Wang L; Han J; Wu Z Int J Nanomedicine; 2017; 12():1699-1715. PubMed ID: 28280336 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]